Alzheimer's Disease Trial, Recruiting NCT06442852 Sponsor: Jiajie Chen Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06442852
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Alzheimer's disease:

  • You have been diagnosed with Alzheimer's disease according to recognised medical diagnostic guidelines (NINCDS-ADRDA criteria)
  • Your dementia has been rated at a certain level of severity or above, based on a standard assessment called the Clinical Dementia Rating scale (score of 0.5 or higher)

For healthy volunteers:

  • You have no complaints or noticeable signs of memory or thinking problems
  • You score above the normal cutoff on a standard memory and thinking test called the MMSE

Who may not be able to join:

For people with Alzheimer's disease:

  • Your memory or thinking problems are caused by a condition other than Alzheimer's disease
  • You are currently experiencing sudden confusion or disorientation (known as delirium)
  • You have a history of drug abuse
  • You have severe hearing loss, difficulty speaking, or other conditions that would affect your ability to complete the assessments

For healthy volunteers:

  • You have a known physical injury or disease affecting the brain
  • You have another serious physical health condition, such as a severe immune system disease

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kai Zheng, Tongji Hospital

Phone: 0086-15927561646

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jiajie Chen
Registry
ClinicalTrials.gov
Start date
3 April 2021
Est. completion
30 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

miR-135a

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov